The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors
Open accessAbstract
A series of 4-alkenyl and 4-alkynyl-3, 4-dihydro-4-(trifluoromethyl)-2-(1H)-quinazolinones were found to be potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) of human immunodeficiency virus type-1 (HIV-1). The 4-alkenyl-3, 4-dihydro-4-(trifluoromethyl)-2-(1H)-quinazolinones DPC 082 and DPC 083 and the 4-alkynyl-3, 4-dihydro-4-(trifluoromethyl)-2-(1H)-quinazolinones DPC 961 and DPC 963 were found to exhibit low nanomolar potency toward wild-type RF virus (IC(90) = 2.0, 2.1, 2.0, and 1.3 nM, respectively) and various single and many multiple amino acid substituted HIV-1 mutant viruses. The increased potency is combined with favorable plasma serum protein binding as demonstrated by improvements in the percent free drug in human plasma when compared to efavirenz: 3.0%, 2.0%, 1.5%, 2. 8%, and 0.2-0.5% for DPC 082, DPC 083, DPC 961, DPC 963, and efavirenz, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Havlir, D. V., Eastman, S., Gamst, A., & Richman, D. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7894-7899.1996 · Cited by 191
. . . from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy.
Mouton, Y. (2000) · PubMed · Cited by 124
Tucker, T. J., Lyle, T. A., Wiscount, C. M., Britcher, S. F., Young, S. D., Sanders, W. M., Lumma, W. C., Goldman, M. E., & O'Brien, J. A. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00041a023 · Cited by 71
Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase
Bacheler, L. T. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0064 · Cited by 43
Self-citationSynthesis and anti-HIV Activity of a Series of 2-Indolinones and Related Analogues
Smallheer, J. M., Otto, M. J., Amaral-Ly, C., Earl, R. A., Myers, M. J., Pennev, P., Montefiori, D. C., & Wuonola, M. A. (1993) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029300400104 · Cited by 20
Cited by
Shibasaki, M., & Kanai, M. (2008) · Chemical Reviews · doi:10.1021/cr078340r · Cited by 620
Asymmetric organocatalysis: an enabling technology for medicinal chemistry
Han, B., He, X.-H., Liu, Y.-Q., He, G., Peng, C., & Li, J.-L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00196a · Cited by 402
HIV‐1 NNRTIs: structural diversity, pharmacophore similarity, and impliations for drug design
Zhan, P., Chen, X., Li, D., Fang, Z., De Clercq, E., & Liu, X. (2013) · Medicinal Research Reviews · doi:10.1002/med.20241 · Cited by 192
Metadata
- Authors
- Corbett, J. W., Ko, S. S., Rodgers, J. D., Gearhart, L. A., Magnus, N. A., Bacheler, L. T., Diamond, S., Jeffrey, S., Klabe, R. M., Cordova, B. C., Garber, S., Logue, K., Trainor, G. L., Anderson, P. S., & Erickson-Viitanen, S. K.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-04-20
- Volume
- 43
- Issue
- 10
- Pages
- 2019-2030
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2039303410
- Cited by
- 305
- References
- 5
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors. https://app.cochat.ai/papers/10.1021/jm990580e
- The paper
- Corbett, J. W., Ko, S. S., Rodgers, J. D., Gearhart, L. A., Magnus, N. A., Bacheler, L. T., Diamond, S., Jeffrey, S., Klabe, R. M., Cordova, B. C., Garber, S., Logue, K., Trainor, G. L., Anderson, P. S., & Erickson-Viitanen, S. K. (2000). Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm990580e
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.